Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic

ABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorpo...

Full description

Bibliographic Details
Main Authors: Stephanie Maya, Leeor Hershkovich, E. Fabian Cardozo-Ojeda, Elham Shirvani-Dastgerdi, Jay Srinivas, Louis Shekhtman, Susan L. Uprichard, Andrew R. Berneshawi, Thomas R. Cafiero, Harel Dahari, Alexander Ploss
Format: Article
Language:English
Published: American Society for Microbiology 2023-08-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.01008-23
_version_ 1797730277940789248
author Stephanie Maya
Leeor Hershkovich
E. Fabian Cardozo-Ojeda
Elham Shirvani-Dastgerdi
Jay Srinivas
Louis Shekhtman
Susan L. Uprichard
Andrew R. Berneshawi
Thomas R. Cafiero
Harel Dahari
Alexander Ploss
author_facet Stephanie Maya
Leeor Hershkovich
E. Fabian Cardozo-Ojeda
Elham Shirvani-Dastgerdi
Jay Srinivas
Louis Shekhtman
Susan L. Uprichard
Andrew R. Berneshawi
Thomas R. Cafiero
Harel Dahari
Alexander Ploss
author_sort Stephanie Maya
collection DOAJ
description ABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorporated mathematical modeling to provide insights into host-HDV dynamics. We analyzed HDV RNA serum viremia in 192 immunocompetent (C57BL/6) and immunodeficient (NRG) mice that did or did not transgenically express the HDV receptor—human sodium taurocholate co-transporting polypeptide (hNTCP). Kinetic analysis indicates an unanticipated biphasic decline consisting of a sharp first-phase and slower second-phase decline regardless of immunocompetence. HDV decline after re-inoculation again followed a biphasic decline; however, a steeper second-phase HDV decline was observed in NRG-hNTCP mice compared to NRG mice. HDV-entry inhibitor bulevirtide administration and HDV re-inoculation indicated that viral entry and receptor saturation are not major contributors to clearance, respectively. The biphasic kinetics can be mathematically modeled by assuming the existence of a non-specific-binding compartment with a constant on/off-rate and the steeper second-phase decline by a loss of bound virus that cannot be returned as free virus to circulation. The model predicts that free HDV is cleared with a half-life of 35 minutes (standard error, SE: 6.3), binds to non-specific cells with a rate of 0.05 per hour (SE: 0.01), and returns as free virus with a rate of 0.11 per hour (SE: 0.02). Characterizing early HDV-host kinetics elucidates how quickly HDV is either cleared or bound depending on the immunological background and hNTCP presence. IMPORTANCE The persistence phase of HDV infection has been studied in some animal models; however, the early kinetics of HDV in vivo is incompletely understood. In this study, we characterize an unexpectedly HDV biphasic decline post-inoculation in immunocompetent and immunodeficient mouse models and use mathematical modeling to provide insights into HDV-host dynamics.
first_indexed 2024-03-12T11:41:58Z
format Article
id doaj.art-b9fcc73b41b943d28bbce73d71cfd85d
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-03-12T11:41:58Z
publishDate 2023-08-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-b9fcc73b41b943d28bbce73d71cfd85d2023-08-31T15:04:20ZengAmerican Society for MicrobiologymBio2150-75112023-08-0114410.1128/mbio.01008-23Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya0Leeor Hershkovich1E. Fabian Cardozo-Ojeda2Elham Shirvani-Dastgerdi3Jay Srinivas4Louis Shekhtman5Susan L. Uprichard6Andrew R. Berneshawi7Thomas R. Cafiero8Harel Dahari9Alexander Ploss10Department of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USADepartment of Medicine, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Stritch School of Medicine, Loyola University Chicago , Maywood, Illinois, USADepartment of Molecular Biology, Princeton University , Princeton, New Jersey, USAABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerated progression to liver fibrosis, cirrhosis, and hepatocellular carcinoma. We characterized early HDV kinetics post-inoculation and incorporated mathematical modeling to provide insights into host-HDV dynamics. We analyzed HDV RNA serum viremia in 192 immunocompetent (C57BL/6) and immunodeficient (NRG) mice that did or did not transgenically express the HDV receptor—human sodium taurocholate co-transporting polypeptide (hNTCP). Kinetic analysis indicates an unanticipated biphasic decline consisting of a sharp first-phase and slower second-phase decline regardless of immunocompetence. HDV decline after re-inoculation again followed a biphasic decline; however, a steeper second-phase HDV decline was observed in NRG-hNTCP mice compared to NRG mice. HDV-entry inhibitor bulevirtide administration and HDV re-inoculation indicated that viral entry and receptor saturation are not major contributors to clearance, respectively. The biphasic kinetics can be mathematically modeled by assuming the existence of a non-specific-binding compartment with a constant on/off-rate and the steeper second-phase decline by a loss of bound virus that cannot be returned as free virus to circulation. The model predicts that free HDV is cleared with a half-life of 35 minutes (standard error, SE: 6.3), binds to non-specific cells with a rate of 0.05 per hour (SE: 0.01), and returns as free virus with a rate of 0.11 per hour (SE: 0.02). Characterizing early HDV-host kinetics elucidates how quickly HDV is either cleared or bound depending on the immunological background and hNTCP presence. IMPORTANCE The persistence phase of HDV infection has been studied in some animal models; however, the early kinetics of HDV in vivo is incompletely understood. In this study, we characterize an unexpectedly HDV biphasic decline post-inoculation in immunocompetent and immunodeficient mouse models and use mathematical modeling to provide insights into HDV-host dynamics.https://journals.asm.org/doi/10.1128/mbio.01008-23viral hepatitishepatitis delta virushepatitis B virusmathematical modelinganimal model
spellingShingle Stephanie Maya
Leeor Hershkovich
E. Fabian Cardozo-Ojeda
Elham Shirvani-Dastgerdi
Jay Srinivas
Louis Shekhtman
Susan L. Uprichard
Andrew R. Berneshawi
Thomas R. Cafiero
Harel Dahari
Alexander Ploss
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
mBio
viral hepatitis
hepatitis delta virus
hepatitis B virus
mathematical modeling
animal model
title Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
title_full Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
title_fullStr Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
title_full_unstemmed Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
title_short Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
title_sort hepatitis delta virus rna decline post inoculation in human ntcp transgenic mice is biphasic
topic viral hepatitis
hepatitis delta virus
hepatitis B virus
mathematical modeling
animal model
url https://journals.asm.org/doi/10.1128/mbio.01008-23
work_keys_str_mv AT stephaniemaya hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT leeorhershkovich hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT efabiancardozoojeda hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT elhamshirvanidastgerdi hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT jaysrinivas hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT louisshekhtman hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT susanluprichard hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT andrewrberneshawi hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT thomasrcafiero hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT hareldahari hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic
AT alexanderploss hepatitisdeltavirusrnadeclinepostinoculationinhumanntcptransgenicmiceisbiphasic